STIENSTRA R, VAN POORTEN IF. The temperature of biupvacaine 0.5% affects the sensory level of spinal anesthesia. Anesth Analg 1988;67:272-6.
It has been shown that anesthetic solutions in vitro equilibrate with body temperature within 1 to 2 minutes (1, 2) . Accordingly, it is assumed that the clinically important densities of anesthetic solutions are those measured at 37°C (3) . The baricity of a solution is the density of that solution divided-by the density of cerebrospinal fluid. By definition, a solution is isobaric if baricity is 1.0000; if baricity is >1.0000, the solution is hyperbaric; i f less, it is hypobaric.
The plain solution of bupivacaine 0.5% at a temperature of 4°C has a density of 1.0040 (courtesy of Astra, The Netherlands); because the mean density of cerebrospinal fluid at 37°C is 1.0003 (1, 3) , the plain solution of 0.5% bupivacaine is slightly hyperbaric. At 37"C, the density of plain bupivacaine 0.5% is 0.9970 (courtesy of Astra, The Netherlands), i.e., the solution is slightly hypobaric. The present study was undertaken to determine if this difference in baricity has any clinical significance.
Patients and Methods
Forty male patients (ASA 1-11) scheduled for urologic surgery under spinal anesthesia were randomly allo-cated to one of two groups. Each group comprised 20 patients. All patients received 3 ml plain bupivacaine 0.5% while sitting; they were kept in the sitting position for 3 minutes after completion of the intrathecal injection of the solution and were then turned into the supine horizontal position. Patients in group 1 received a solution that had been previously equilibrated in a stove (MELAG Apparate GmbH W-Germany, type 85) to 37°C for at least 1 day. Patients in group 2 received a solution that had been equilibrated in a refrigerator to 4°C for at least 1 day. Syringes used to administer the bupivacaine solution were also equilibrated to 37°C and 4"C, respectively. The study was approved by the Ethical Committee of our institution and oral consent was obtained from all patients.
Premedication consisted of lorazepam 1 mg orally the night before surgery. Before induction of spinal anesthesia 500 ml Ringer's solution were administered by rapid intravenous infusion, followed, after completion of the intrathecal injection, by 500 ml'of a plasma expander (Haemaccel) at a slower rate. Dural puncture was performed with the patient in the sitting position at the L S L 4 interspace using a standard midline or paramedian approach and a 25-gauge spinal needle.
Blood pressure and pulse rate were measured before injection (T = 0) and at 5-minute intervals after injection for 20 minutes (T = 5-20) using an automatic BUPlVACAlNE TEMPERATURE AND SPlNAL ANESTHESlA cycling device (Dinamap). ECG was monitored continuously.
Measurements of the levels of sensory changes were made 10 and 20 minutes after injection of the bupivacaine solution. Sensory loss was measured in the anterior axillary line by pinprick using a shortbevelled 25-gauge needle. Temperature loss was measured using a cold bottle containing a frozen salt solution. The segment at which the patient was not capable of recognizing the temperature of the bottle as well as the segment of loss of sensation to pinprick were recorded. Motor blockade was assessed 10 and 20 minutes after injection using a 0-3 scale as described by Bromage (4) . All punctures and observations were made by the authors under "observer blind" conditions.
Results are expressed as means k SEM. Statistical analysis used the Wilcoxon test for matched pairs for intragroup variations and the Mann-Whitney-Zl test for intergroup comparisons. For comparison of differences in motor blockade between the two groups the , $ test according to Yates was used. P < 0.05 was taken as indicative of statistically significant differences.
Results
There were no statistical significant differences between the two groups regarding age, height, or Figure 1 . Segmental levels of temperature loss (temperature spread) and loss of sensation to pinprick (analgesia spread) 20 minutes after injection. The horizontal axis shows the thoracic segment at which temperature loss and loss of sensation to pinprick were measured; the vertical axis shows the number of patients. The differences between the two groups regarding temperature and analgesia spread were statistically significant. .Group 1: plain bupivacaine, 37°C; OGroup 2: plain bupivacaine, 4°C.
weight ( Table 1 ). The segmental level of temperature loss after 10 minutes was T4 in group 1 and T10 in group 2; after 20 minutes, these levels were T3 and T8, respectively. The segmental level of loss of sensation to pinprick after 10 minutes was T5 in group 1 and T10 in group 2; after 20 minutes these levels were T4 and T9, respectively. The differences in sensory levels between groups were statistically significant at both 10 and at 20 minutes ( Table 2 ). The ranges of levels are shown in Figure 1 . The differences in motor blockade between the two groups at 10 and 20 minutes were not significant. The distribution of motor blockade is shown in Figure 2 .
Systolic blood pressures decreased in both groups, decreases being significantly below baseline levels after 5, 10, 15, and 20 minutes, the decrease being more pronounced in group 1. There was no significant difference in systolic blood pressures at T = 0 between groups. Differences between decreases in systolic blood pressures in both groups were signifi- Figure 2 . Degree of motor blockade 10 minutes after injection (A) and 20 minutes after injection (B). The horizontal axis shows the Bromage scale: 0 = no motor block; 1 = inability to raise the extended leg; 2 = inability to flex the knee; 3 = complete motor block. The vertical axis shows the number of patients. Differences in motor blockade were statistically not significant. .Group 1: plain bupivacaine, 37°C; OGroup 2: plain bupivacaine, -IT. cant at T = 10. In three patients in group 1 and one patient in group 2 the decrease in blood pressure necessitated the use of ephedrine. Apart from a significant increase in heart rate at T = 5 in group 1, heart rates did not change significantly; intergroup comparison of the changes in heart rates showed no significant difference. Hemodynamic data are summarized in Table 3 .
In one patient in group 2 (analgesia level T12), analgesia was not sufficient and had to be supplemented with nitrous oxide. One patient in group 2 developed postspinal headache, which was successfully treated with an epidural blood patch. 
Discussion
Although the plain solution of bupivacaine 0.5% has been recognized as a suitable agent for spinal anesthesia (5-12), one of the major criticisms of its use for this purpose is the fact that predictability with regard to sensory spread is poor (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Among the factors that affect the distribution of local anesthetic solutions in the cerebrospinal fluid, the baricity of the injected solution is well established (3) . Although the plain solution of bupivacaine 0.5% is slightly hypobaric at 37"C, it is generally regarded and used as an isobaric solution (3).
In 'an attempt to explain the absence of difference in sensory spread between isobaric and hyperbaric solutions of tetracaine, Levin et al. (23) drew attention to the possibility that the time needed for thermal equilibration of a solution injected at room temperature might be a factor of influence. The assumption that injected solutions reach thermal equilibration in the cerebrospinal fluid within 1 to 2 minutes is based on the work of Davis and Kmg (1) and Ernst (2) ; apart from the high room temperatures (27°C in the former and 23°C in the latter) both studies were in vitro studies. In none of the studies in which plain bupivacaine 0.5% was used was temperature of the injected solution controlled. As is shown in this study, injecting bupivacaine 0.5% at 37°C not only results in a significantly higher cephalad spread, 1988;67:772-6 but also reduces the variability of sensory spread considerably, as is shown by a relatively small SEM of 0.3.
The fact that the cold solution of 4°C changes from initially slightly hyperbaric to slightly hypobaric during thermal equilibration in the cerebrospinal fluid explains the lower cephalad spread; individual variation in the time needed for thermal equilibration could well explain the greater variability in sensory spread seen with the cold solution. This implies that the time needed for thermal equilibration in the cerebrospinal fluid is an important factor in determining cephalad spread when using plain bupivacaine. It seems reasonable to assume that in most clinics the temperature of the injectate will be the same as room temperature. Because the time needed for thermal equilibration is inversely related to the temperature of the solution, room temperature itself or the temperature of the place of storage of the solution becomes an important factor. It stands to reason to assume that the ensuing levels of sensory blockade after injecting bupivacaine 0.5% at room temperature will be somewhere between those seen with solutions of 4°C and 37°C. The fact that room temperature will be influenced by geographic location and by the time of year might explain, together with individual variation in the time needed for thermal equilibration, the great variability of sensory spread of plain bupivacaine solutions as seen in the literature.
The decrease in systolic blood pressure was greatest in group 1, as might be expected because of higher cephalad spread, although statistical analysis showed the differences to be significant only at T = 10. When Bonferroni's procedure is applied this difference at T = 10 remains significant. Considering the data, we believe that the lack of significance at T = 5, T = 15, and T = 20 should be explained by a type I1 error being made due to considerable variation in blood pressures.
Apart from a significant increase at T = 5 in group 1, the heart rates showed no significant changes; when Bonferroni's procedure is applied, the increase in heart rate at T = 5 in group 1 loses significance; the conclusion that it involves a spurious statistical significance seems therefore warranted. As can be seen from Figure 2 , there were no major differences in motor blockade; in all patients motor blockade was adequate for surgery.
In conclusion, under the conditions of the present study the time needed for thermal equilibration in the cerebrospinal fluid and hence the temperature of the bupivacaine 0.5% solution is an important factor in determining sensory spread. When using a solution that has been equilibrated previously to 37"C, predict-ability of the ensuing level of analgesia is good. In case a high level of sensory blockade using bupivacaine 0.5% is desired, the solution should be equilibrated to 37°C.
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